ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

SLRN ACELYRIN Inc

4,14
0,09 (2,22%)
Zuletzt aktualisiert: 21:25:22
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ACELYRIN Inc SLRN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,09 2,22% 4,14 21:25:22
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,07 4,05 4,30 4,05
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.5.202413:00GLOBEACELYRIN, INC. Announces Lonigutamab Phase 1/2..
28.5.202423:20EDGAR2Form 8-K/A - Current report: [Amend]
25.5.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.5.202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.5.202401:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.5.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.5.202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.5.202401:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.5.202422:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202414:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09.5.202414:13EDGAR2Form 8-K - Current report
09.5.202414:01GLOBEACELYRIN, INC. Provides Business Update and Highlights Key..
09.5.202414:00GLOBEACELYRIN, INC. Announces Leadership Transition
29.4.202422:05GLOBEACELYRIN, INC. to Report First Quarter 2024 Financial..
28.3.202421:05GLOBEACELYRIN, INC. Reports Full Year 2023 Financial Results and..
27.3.202421:01GLOBEAvalo Acquires Anti-IL-1β mAb and Announces Private..
20.3.202412:00GLOBEACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept..
11.3.202413:05EDGAR2Form 8-K - Current report
11.3.202413:02GLOBEACELYRIN, INC. Announces Positive Top-line Results from Its..
11.3.202413:00GLOBEACELYRIN, INC. Announces Long-term 32-Week Data from the..
15.2.202422:05GLOBEACELYRIN, INC. Appoints Agnes Lee as Senior Vice President,..
12.1.202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12.1.202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
20.12.202322:38EDGAR2Form 8-K - Current report
20.12.202322:30GLOBEACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors
18.12.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12.12.202314:00PRNUSDiCello Levitt LLP Announces Investor Class Action Lawsuit..
04.12.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28.11.202312:03IHMARKETNEWSTuesday’s Wall Street Highlights: Zscaler, Shein, 3M, Meta..
28.11.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27.11.202322:31EDGAR2Form 8-K - Current report
27.11.202322:30GLOBEACELYRIN, INC. Provides Update on Izokibep Clinical..
21.11.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
07.11.202322:23EDGAR2Form 8-K - Current report
07.11.202322:05GLOBEACELYRIN, INC. Reports Third Quarter 2023 Financial Results..
06.11.202313:00GLOBEACELYRIN, INC. Appoints Patricia Turney as Chief Technical..
31.10.202321:30GLOBEACELYRIN, INC. to Report Third Quarter 2023 Financial..
06.10.202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202313:00GLOBEACELYRIN, INC. Scales for Continued Late-Stage Growth with..
12.9.202315:23IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
12.9.202313:29IHMARKETNEWSTuesday’s Wall Street Highlights: Apple, Acelyrin, WestRock,..
12.9.202302:03DJNStocks to Watch: Oracle, Acelyrin, Humacyte
11.9.202322:05GLOBEACELYRIN, INC. Announces Top-Line Results from..
06.9.202313:00GLOBEACELYRIN, INC. to Present at the Morgan Stanley 21st Annual..
21.8.202322:03EDGAR2Form 8-K - Current report
19.8.202300:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.8.202300:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.8.202300:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..